Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages
- PMID: 9531308
Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages
Abstract
Trypanosoma cruzi target molecules that might regulate the host immune responses have not yet been fully identified. In the present study, we demonstrate that the parasite-released molecule (Tc52) was able to synergize with IFN-gamma to stimulate nitric oxide production by macrophages. This synergistic effect was also observed at the level of inducible nitric oxide synthase gene expression. Furthermore, Tc52 was also shown to induce gene expression for IL-1alpha, IL-12, and IL-10. Moreover, the combination of Tc52 and IFN-gamma down-regulates IL-1alpha and IL-10 gene expression, but not IL-12. Isotype profiles and Tc52 or anti-CD3-induced T cell proliferation were also analyzed, indicating that active immunization with Tc52 partially relieves the immunosuppression observed during the acute phase of the disease. Moreover, under conditions of experimental infection, the Tc52 appears immunologically silent, failing to elicit Ab response and lymphocyte proliferation during the initial acute phase infection. Following active immunization, Tc52 was capable of stimulating T cell proliferation and Ab production with a predominance of IgG1, IgG2a, IgG2b, IgG3, and to a lesser extent IgA. Taken together, these results demonstrate that T. cruzi Tc52-released Ag could be involved in the immunoregulatory processes. The immune response against Tc52 that appears late in the T. cruzi infection may play a role in the modulation of its biological function(s).
Similar articles
-
Recombinant SSP4 protein from Trypanosoma cruzi amastigotes regulates nitric oxide production by macrophages.Parasite Immunol. 2004 Oct;26(10):409-18. doi: 10.1111/j.0141-9838.2004.00729.x. Parasite Immunol. 2004. PMID: 15752118
-
[TH1 response in the experimental infection with Trypanosoma cruzi].Medicina (B Aires). 1999;59 Suppl 2:84-90. Medicina (B Aires). 1999. PMID: 10668248 Spanish.
-
Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection.J Immunol. 1995 Oct 15;155(8):3955-63. J Immunol. 1995. PMID: 7561103
-
[Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].Rev Argent Microbiol. 1996 Apr-Jun;28(2):99-109. Rev Argent Microbiol. 1996. PMID: 8768488 Review. Spanish.
-
Macrophages in experimental Chagas' disease.Immunol Ser. 1994;60:495-502. Immunol Ser. 1994. PMID: 8251589 Review.
Cited by
-
Peptide-based analysis of the amino acid sequence important to the immunoregulatory function of Trypanosoma cruzi Tc52 virulence factor.Immunology. 2003 May;109(1):147-55. doi: 10.1046/j.1365-2567.2003.01637.x. Immunology. 2003. PMID: 12709028 Free PMC article.
-
Trypanosoma cruzi High Mobility Group B (TcHMGB) can act as an inflammatory mediator on mammalian cells.PLoS Negl Trop Dis. 2017 Feb 8;11(2):e0005350. doi: 10.1371/journal.pntd.0005350. eCollection 2017 Feb. PLoS Negl Trop Dis. 2017. PMID: 28178282 Free PMC article.
-
Immunity and vaccine development efforts against Trypanosoma cruzi.Acta Trop. 2019 Dec;200:105168. doi: 10.1016/j.actatropica.2019.105168. Epub 2019 Sep 9. Acta Trop. 2019. PMID: 31513763 Free PMC article. Review.
-
Immune suppression by recombinant interleukin (rIL)-12 involves interferon gamma induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect.J Exp Med. 1998 Nov 2;188(9):1603-10. doi: 10.1084/jem.188.9.1603. J Exp Med. 1998. PMID: 9802972 Free PMC article.
-
Myeloid-Derived Suppressor Cells in Trypanosoma cruzi Infection.Front Cell Infect Microbiol. 2021 Aug 27;11:737364. doi: 10.3389/fcimb.2021.737364. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34513737 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous